Selected research
Industry Growth & Trends
Global Kidney (Renal) Fibrosis Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Kidney (Renal) Fibrosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Kidney (Renal) Fibrosis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Kidney (Renal) Fibrosis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Kidney (Renal) Fibrosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Kidney (Renal) Fibrosis market include Merck, Roche, Pfizer, ProMetic Life-Sciences Inc., La Jolla Pharmaceutical Company, InterMune, Genzyme Corporation, Galectin Therapeutics and BioLine Rx Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Kidney (Renal) Fibrosis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Kidney (Renal) Fibrosis market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Kidney (Renal) Fibrosis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Kidney (Renal) Fibrosis.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Kidney (Renal) Fibrosis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Kidney (Renal) Fibrosis Market by Company
Merck
Roche
Pfizer
ProMetic Life-Sciences Inc.
La Jolla Pharmaceutical Company
InterMune
Genzyme Corporation
Galectin Therapeutics
BioLine Rx Ltd
Kidney (Renal) Fibrosis Segment by Type
Vasopeptidase Inhibitors
Angiotensin Converting enzyme (ACE) Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Renin Inhibitors
Pirfenidone
Kidney (Renal) Fibrosis Segment by Application
Clinic
Hospital
Research Center
Kidney (Renal) Fibrosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney (Renal) Fibrosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Kidney (Renal) Fibrosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney (Renal) Fibrosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Kidney (Renal) Fibrosis companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Vasopeptidase Inhibitors
- Angiotensin Converting enzyme (ACE) Inhibitors
- Angiotensin II Receptor Blockers (ARBs)
- Renin Inhibitors
- Pirfenidone
Applications
- Clinic
- Hospital
- Research Center
Companies covered
- Merck
- Roche
- Pfizer
- ProMetic Life-Sciences Inc.
- La Jolla Pharmaceutical Company
- InterMune
- Genzyme Corporation
- Galectin Therapeutics
- BioLine Rx Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Kidney (Renal) Fibrosis Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Kidney (Renal) Fibrosis Market Size by Region (2021-2032)
- 1.4.1 Global Kidney (Renal) Fibrosis Market Size by Region (2021-2026)
- 1.4.2 Global Kidney (Renal) Fibrosis Market Size by Region (2027-2032)
- 1.5 Key Regions Kidney (Renal) Fibrosis Market Size (2021-2032)
- 1.5.1 North America Kidney (Renal) Fibrosis Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Kidney (Renal) Fibrosis Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Kidney (Renal) Fibrosis Market Size Growth Rate (2021-2032)
- 1.5.4 South America Kidney (Renal) Fibrosis Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Kidney (Renal) Fibrosis Market Size Growth Rate (2021-2032)
2 Kidney (Renal) Fibrosis Market by Type
- 2.1 Type Introduction
- 2.1.1 Vasopeptidase Inhibitors
- 2.1.2 Angiotensin Converting enzyme (ACE) Inhibitors
- 2.1.3 Angiotensin II Receptor Blockers (ARBs)
- 2.1.4 Renin Inhibitors
- 2.1.5 Pirfenidone
- 2.2 Global Kidney (Renal) Fibrosis Market Size by Type
- 2.2.1 Global Kidney (Renal) Fibrosis Market Size Overview by Type (2021-2032)
- 2.2.2 Global Kidney (Renal) Fibrosis Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Kidney (Renal) Fibrosis Market Size Forecasted by Type (2027-2032)
- 2.3 Global Kidney (Renal) Fibrosis Market Size by Regions
- 2.3.1 North America Kidney (Renal) Fibrosis Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Kidney (Renal) Fibrosis Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Kidney (Renal) Fibrosis Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Kidney (Renal) Fibrosis Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Kidney (Renal) Fibrosis Market Size Breakdown by Type (2021-2026)
3 Kidney (Renal) Fibrosis Market by Application
- 3.1 Type Introduction
- 3.1.1 Clinic
- 3.1.2 Hospital
- 3.1.3 Research Center
- 3.2 Global Kidney (Renal) Fibrosis Market Size by Application
- 3.2.1 Global Kidney (Renal) Fibrosis Market Size Overview by Application (2021-2032)
- 3.2.2 Global Kidney (Renal) Fibrosis Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Kidney (Renal) Fibrosis Market Size Forecasted by Application (2027-2032)
- 3.3 Global Kidney (Renal) Fibrosis Market Size by Regions
- 3.3.1 North America Kidney (Renal) Fibrosis Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Kidney (Renal) Fibrosis Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Kidney (Renal) Fibrosis Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Kidney (Renal) Fibrosis Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Kidney (Renal) Fibrosis Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Kidney (Renal) Fibrosis Industry Trends
- 4.2 Kidney (Renal) Fibrosis Industry Drivers
- 4.3 Kidney (Renal) Fibrosis Industry Opportunities and Challenges
- 4.4 Kidney (Renal) Fibrosis Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Kidney (Renal) Fibrosis Revenue (2021-2026)
- 5.2 Global Kidney (Renal) Fibrosis Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Kidney (Renal) Fibrosis Key Company Headquarters & Area Served
- 5.4 Global Kidney (Renal) Fibrosis Company, Product Type & Application
- 5.5 Global Kidney (Renal) Fibrosis Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Kidney (Renal) Fibrosis Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Kidney (Renal) Fibrosis Players Market Share by Revenue in 2025
- 5.6.3 2025 Kidney (Renal) Fibrosis Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Merck
- 6.1.1 Merck Company Information
- 6.1.2 Merck Business Overview
- 6.1.3 Merck Kidney (Renal) Fibrosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Merck Kidney (Renal) Fibrosis Product Portfolio
- 6.1.5 Merck Recent Developments
- 6.2 Roche
- 6.2.1 Roche Company Information
- 6.2.2 Roche Business Overview
- 6.2.3 Roche Kidney (Renal) Fibrosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Roche Kidney (Renal) Fibrosis Product Portfolio
- 6.2.5 Roche Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Company Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Kidney (Renal) Fibrosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Pfizer Kidney (Renal) Fibrosis Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 ProMetic Life-Sciences Inc.
- 6.4.1 ProMetic Life-Sciences Inc. Company Information
- 6.4.2 ProMetic Life-Sciences Inc. Business Overview
- 6.4.3 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Product Portfolio
- 6.4.5 ProMetic Life-Sciences Inc. Recent Developments
- 6.5 La Jolla Pharmaceutical Company
- 6.5.1 La Jolla Pharmaceutical Company Company Information
- 6.5.2 La Jolla Pharmaceutical Company Business Overview
- 6.5.3 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Product Portfolio
- 6.5.5 La Jolla Pharmaceutical Company Recent Developments
- 6.6 InterMune
- 6.6.1 InterMune Company Information
- 6.6.2 InterMune Business Overview
- 6.6.3 InterMune Kidney (Renal) Fibrosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 InterMune Kidney (Renal) Fibrosis Product Portfolio
- 6.6.5 InterMune Recent Developments
- 6.7 Genzyme Corporation
- 6.7.1 Genzyme Corporation Company Information
- 6.7.2 Genzyme Corporation Business Overview
- 6.7.3 Genzyme Corporation Kidney (Renal) Fibrosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Genzyme Corporation Kidney (Renal) Fibrosis Product Portfolio
- 6.7.5 Genzyme Corporation Recent Developments
- 6.8 Galectin Therapeutics
- 6.8.1 Galectin Therapeutics Company Information
- 6.8.2 Galectin Therapeutics Business Overview
- 6.8.3 Galectin Therapeutics Kidney (Renal) Fibrosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Galectin Therapeutics Kidney (Renal) Fibrosis Product Portfolio
- 6.8.5 Galectin Therapeutics Recent Developments
- 6.9 BioLine Rx Ltd
- 6.9.1 BioLine Rx Ltd Company Information
- 6.9.2 BioLine Rx Ltd Business Overview
- 6.9.3 BioLine Rx Ltd Kidney (Renal) Fibrosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 BioLine Rx Ltd Kidney (Renal) Fibrosis Product Portfolio
- 6.9.5 BioLine Rx Ltd Recent Developments
7 North America
- 7.1 North America Kidney (Renal) Fibrosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Kidney (Renal) Fibrosis Market Size by Country (2021-2026)
- 7.3 North America Kidney (Renal) Fibrosis Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Kidney (Renal) Fibrosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Kidney (Renal) Fibrosis Market Size by Country (2021-2026)
- 8.3 Europe Kidney (Renal) Fibrosis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Kidney (Renal) Fibrosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Kidney (Renal) Fibrosis Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Kidney (Renal) Fibrosis Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Kidney (Renal) Fibrosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Kidney (Renal) Fibrosis Market Size by Country (2021-2026)
- 10.3 South America Kidney (Renal) Fibrosis Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Kidney (Renal) Fibrosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Kidney (Renal) Fibrosis Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Kidney (Renal) Fibrosis Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst